vs
DSS, INC.(DSS)与Profound Medical Corp.(PROF)财务数据对比。点击上方公司名可切换其他公司
Profound Medical Corp.的季度营收约是DSS, INC.的1.4倍($6.0M vs $4.1M),Profound Medical Corp.净利率更高(-136.8% vs -420.6%,领先283.9%)
DSS Inc.是一家多元化技术企业,提供产品防伪认证、安全身份识别、区块链创新应用、数字资产管理工具及医疗技术相关产品,主要服务北美、亚洲及欧洲市场,覆盖消费品、金融服务、医疗等核心领域。
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业,专注于为医疗领域开发并提供相关软件产品,面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年,该公司全球员工规模超9200人,业务覆盖56个国家,拥有超过160万用户。
DSS vs PROF — 直观对比
营收规模更大
PROF
是对方的1.4倍
$4.1M
净利率更高
PROF
高出283.9%
-420.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $4.1M | $6.0M |
| 净利润 | $-17.4M | $-8.2M |
| 毛利率 | — | 66.8% |
| 营业利润率 | -98.1% | -123.3% |
| 净利率 | -420.6% | -136.8% |
| 营收同比 | -23.8% | — |
| 净利润同比 | 47.2% | — |
| 每股收益(稀释后) | — | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DSS
PROF
| Q4 25 | $4.1M | $6.0M | ||
| Q3 25 | $6.4M | $5.1M | ||
| Q2 25 | $5.3M | $2.0M | ||
| Q1 25 | $5.0M | $2.3M | ||
| Q4 24 | $5.4M | — | ||
| Q3 24 | $5.6M | — | ||
| Q2 24 | $4.2M | — | ||
| Q1 24 | $3.9M | — |
净利润
DSS
PROF
| Q4 25 | $-17.4M | $-8.2M | ||
| Q3 25 | $-2.2M | $-8.0M | ||
| Q2 25 | $-2.6M | $-15.7M | ||
| Q1 25 | $-5.3M | $-10.7M | ||
| Q4 24 | $-32.9M | — | ||
| Q3 24 | $-5.3M | — | ||
| Q2 24 | $-4.7M | — | ||
| Q1 24 | $-4.1M | — |
毛利率
DSS
PROF
| Q4 25 | — | 66.8% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 81.7% | ||
| Q1 25 | — | 79.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率
DSS
PROF
| Q4 25 | -98.1% | -123.3% | ||
| Q3 25 | -50.6% | -176.2% | ||
| Q2 25 | -64.8% | -696.9% | ||
| Q1 25 | -75.2% | -477.0% | ||
| Q4 24 | -522.7% | — | ||
| Q3 24 | -83.4% | — | ||
| Q2 24 | -117.2% | — | ||
| Q1 24 | -120.9% | — |
净利率
DSS
PROF
| Q4 25 | -420.6% | -136.8% | ||
| Q3 25 | -34.9% | -157.7% | ||
| Q2 25 | -49.3% | -792.3% | ||
| Q1 25 | -106.9% | -458.1% | ||
| Q4 24 | -606.7% | — | ||
| Q3 24 | -94.4% | — | ||
| Q2 24 | -111.2% | — | ||
| Q1 24 | -105.2% | — |
每股收益(稀释后)
DSS
PROF
| Q4 25 | — | $0.27 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | — | $0.36 | ||
| Q4 24 | $-4.64 | — | ||
| Q3 24 | $-0.75 | — | ||
| Q2 24 | $-0.66 | — | ||
| Q1 24 | $-0.58 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $8.9M | $59.7M |
| 总债务越低越好 | $44.7M | $4.5M |
| 股东权益账面价值 | $-832.0K | $66.4M |
| 总资产 | $67.6M | $77.5M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势,按日历期对齐
现金及短期投资
DSS
PROF
| Q4 25 | $8.9M | $59.7M | ||
| Q3 25 | $8.7M | $24.8M | ||
| Q2 25 | $12.4M | $35.2M | ||
| Q1 25 | $17.3M | $46.4M | ||
| Q4 24 | $14.3M | — | ||
| Q3 24 | $18.9M | — | ||
| Q2 24 | $20.3M | — | ||
| Q1 24 | $17.7M | — |
总债务
DSS
PROF
| Q4 25 | $44.7M | $4.5M | ||
| Q3 25 | $50.2M | $4.5M | ||
| Q2 25 | $43.9M | $4.5M | ||
| Q1 25 | $49.3M | $4.5M | ||
| Q4 24 | $57.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
DSS
PROF
| Q4 25 | $-832.0K | $66.4M | ||
| Q3 25 | $14.2M | $32.1M | ||
| Q2 25 | $15.7M | $39.3M | ||
| Q1 25 | $17.9M | $50.8M | ||
| Q4 24 | $19.9M | — | ||
| Q3 24 | $52.1M | — | ||
| Q2 24 | $55.2M | — | ||
| Q1 24 | $59.9M | — |
总资产
DSS
PROF
| Q4 25 | $67.6M | $77.5M | ||
| Q3 25 | $92.1M | $42.3M | ||
| Q2 25 | $93.4M | $49.7M | ||
| Q1 25 | $92.4M | $60.9M | ||
| Q4 24 | $106.5M | — | ||
| Q3 24 | $142.7M | — | ||
| Q2 24 | $144.4M | — | ||
| Q1 24 | $148.5M | — |
负债/权益比
DSS
PROF
| Q4 25 | — | 0.07× | ||
| Q3 25 | 3.54× | 0.14× | ||
| Q2 25 | 2.80× | 0.11× | ||
| Q1 25 | 2.76× | 0.09× | ||
| Q4 24 | 2.87× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-1.6M | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
DSS
PROF
| Q4 25 | $-1.6M | $-6.6M | ||
| Q3 25 | $-8.0M | $-9.6M | ||
| Q2 25 | $2.1M | $-13.7M | ||
| Q1 25 | $-1.6M | $-8.3M | ||
| Q4 24 | $-2.9M | — | ||
| Q3 24 | $-315.0K | — | ||
| Q2 24 | $-3.4M | — | ||
| Q1 24 | $-2.1M | — |
自由现金流
DSS
PROF
| Q4 25 | — | — | ||
| Q3 25 | $-8.1M | — | ||
| Q2 25 | $2.0M | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-3.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-3.5M | — | ||
| Q1 24 | $-2.2M | — |
自由现金流率
DSS
PROF
| Q4 25 | — | — | ||
| Q3 25 | -126.5% | — | ||
| Q2 25 | 37.4% | — | ||
| Q1 25 | -34.1% | — | ||
| Q4 24 | -54.9% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -81.9% | — | ||
| Q1 24 | -55.6% | — |
资本支出强度
DSS
PROF
| Q4 25 | — | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图